Capstone Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.35M | Sell |
42,189
-1,735
| -4% | -$96.7K | 0.07% | 353 |
|
|
2017
Q1 | $2.39M | Buy |
43,924
+970
| +2% | +$52.8K | 0.07% | 352 |
|
|
2016
Q4 | $2.51M | Buy |
42,954
+3,342
| +8% | +$195K | 0.07% | 321 |
|
|
2016
Q3 | $2.14M | Buy |
39,612
+3,920
| +11% | +$211K | 0.06% | 370 |
|
|
2016
Q2 | $2.63M | Buy |
35,692
+1,945
| +6% | +$143K | 0.08% | 300 |
|
|
2016
Q1 | $2.16M | Buy |
33,747
+2,870
| +9% | +$183K | 0.06% | 368 |
|
|
2015
Q4 | $2.12M | Buy |
30,877
+2,950
| +11% | +$203K | 0.06% | 377 |
|
|
2015
Q3 | $1.65M | Buy |
27,927
+805
| +3% | +$47.6K | 0.05% | 415 |
|
|
2015
Q2 | $1.81M | Sell |
27,122
-130
| -0.5% | -$8.65K | 0.05% | 408 |
|
|
2015
Q1 | $1.76M | Buy |
27,252
+2,895
| +12% | +$187K | 0.05% | 437 |
|
|
2014
Q4 | $1.44M | Sell |
24,357
-1,250
| -5% | -$73.8K | 0.04% | 490 |
|
|
2014
Q3 | $1.31M | Buy |
25,607
+1,240
| +5% | +$63.5K | 0.04% | 463 |
|
|
2014
Q2 | $1.18M | Sell |
24,367
-37,686
| -61% | -$1.83M | 0.04% | 539 |
|
|
2014
Q1 | $3.22M | Sell |
62,053
-44,291
| -42% | -$2.3M | 0.1% | 235 |
|
|
2013
Q4 | $5.65M | Sell |
106,344
-90,648
| -46% | -$4.82M | 0.16% | 141 |
|
|
2013
Q3 | $9.12M | Sell |
196,992
-10,355
| -5% | -$479K | 0.22% | 87 |
|
|
2013
Q2 | $9.27M | Buy |
+207,347
| New | +$9.27M | 0.24% | 75 |
|